CRNX - Balance Sheet - Crinetics Pharmaceuticals, Inc.

Current Liabilities	59.7 M
Accounts Payable	5.85 M
Short-Term Debt	7.15 M
Other Current Liabilities	46.7 M
Non-Current Liabilities	50.1 M
Long-Term Debt	0
Other Non-Current Liabilities	50.1 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	264.5	54.9	32.7	200.7	93.1	40.3	45.0	14.2	12.2
Short Term Investments	1 089.5	503.7	301.8	133.0	77.8	78.1	118.9	0	0
Receivables	0	9.4	0	2.0	1.8	0	0	0.7	72 K
Inventory	0	0	0	8.1	(1.8)	(1.4)	0	0.1	98 K
Other Current Assets	1.7	6.2	10.8	8.1	4.8	1.3	0.9	0.2	43 K
Total Current Assets	1 375.4	574.2	345.2	344.7	177.5	123.3	166.7	15.2	12.4
PP&E	55.6	57.4	5.0	4.7	5.4	6.5	4.2	0.4	0.2
Intangible Assets	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	1.8	2.0	1.0	0.5	0.5	0.5	0	0
Other Long Term Assets	3.6	2.0	37 K	0.6	40 K	82 K	0	33 K	10 K
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	1 434.6	635.4	352.2	351.0	183.4	130.4	171.4	15.6	12.6
LIABILITIES
Accounts Payable	5.9	6.5	6.9	3.4	3.5	2.7	1.5	0.4	0.3
Short Term Debt	7.2	4.2	1.1	0	0	0	0	0	49 K
Other Current Liabilities	44.5	31.2	17.5	12.6	7.0	5.6	6.5	0.5	0.5
Total Current Liabilities	59.7	43.9	27.7	16.0	10.5	8.3	7.9	0.9	0.9
Long Term Debt	0	47.6	2.0	3.1	4.0	4.8	0	0	0.2
Deferred Tax Income	0	0	(6.1)	0	0	0	0	0	0
Other Liabilities	50.1	0	0	2 K	23 K	49 K	3.3	29.7	17.8
Total Liabilities	109.8	96.2	35.8	19.1	14.5	13.2	11.2	30.6	18.8
EQUITY
Common Stock	2 276.0	1 191.8	759.4	607.6	336.5	210.8	24 K	1 K	1 K
Retained Earnings	(952.1)	(653.7)	(439.2)	(275.3)	(167.6)	(93.8)	(43.4)	(16.3)	(7.1)
Other Accumulative Comprehensive Income/Loss	1.0	1.0	(3.9)	(0.4)	25 K	0.1	61 K	(0.3)	(0.2)
Total Equity	1 324.8	539.1	(439.2)	(275.3)	(167.6)	(93.8)	(43.4)	(15.0)	(6.2)
Total Liabilities and Equity	1 434.6	635.4	(403.3)	(256.2)	(153.1)	(80.6)	(32.2)	15.6	12.6
SHARES OUTSTANDING
Common Shares Outstanding	80.8	58.1	52.0	38.4	30.4	24.2	12.1	13.9	13.9

Free